查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1559454

全球心肺旁路設備市場：洞察、競爭格局、市場預測：2030年

Cardiopulmonary Bypass Equipment - Market Insights, Competitive Landscape, and Market Forecast - 2030
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

2023年體外循環設備市場規模為4.0​​518億美元。預計到2030年，該市場將達到 5.1682億美元，2024年至2030年的預測期內年複合成長率為 4.14%。全球心血管和呼吸系統疾病盛行率不斷上升以及手術干預的需求不斷增加，推動了對心肺旁路設備的需求。冠狀動脈疾病、心臟衰竭和先天性心臟病等疾病通常需要複雜的手術，而體外循環機可以幫助完成這些手術。其次，由於人口老化和醫療技術的進步，外科手術數量不斷增加，推動了對體外循環設備的需求。隨著手術數量的增加，對可靠、高效的體外循環機的需求也增加。第三，認識和篩檢計畫有助於心血管和呼吸系統疾病的早期發現和診斷。早期發現通常會導致及時的手術干預，進一步推動對體外循環設備的需求。此外，全球主要市場參與者不斷增加的產品發布和批准日益擴大先進心肺機的可用性和可及性。技術創新和設計改進創造更有效率、更安全、更易於使用的設備，在2024年至2030年的預測期內提高醫療保健專業人員的採用率。

根據英國心臟基金會的最新資料 (2024年) ，全球約有 6.2億人，約每 13 人中就有 1 人患有心臟和循環系統疾病。此外，根據同一資料，2021年歐洲有1億人患有心臟病和循環系統疾病，亞洲和澳洲有3.4億人患有心臟病和循環系統疾病。此外，根據英國心臟基金會提供的最新資料 (2024年) ，冠狀動脈心臟病 (缺血性) 心臟病是世界上最常被診斷的疾病，影響全球約 2億人。約 1.1億男性和 8,000萬名女性受到影響。此外，大約有 5,600萬名女性和 4,500萬名男性是中風倖存者。據估計，全世界至少有 1,300萬人患有先天性心臟病，還有數百萬人可能未被診斷出來。

心臟和循環系統疾病，如冠心病 (缺血性) 、心房顫動和中風，由於其普遍性和治療的複雜性 (通常需要手術干預) 而通常被稱為心肺旁路設備，推動了需求。這些手術嚴重依賴心肺旁路機來維持循環和呼吸功能。冠心病會導致斑塊堆積並減少血流量，通常需要進行冠狀動脈旁路移植術 (CABG) ，顯著增加對心肺機的需求。心房顫動是最常見的心律不整，會增加中風和心臟衰竭的風險，導致迷宮手術和導管消融等手術，這些手術也依賴體外循環支持。同樣，由於血流阻塞引起的中風通常需要依靠體外循環機進行手術干預來恢復循環，進一步推動了全球市場的成長。

本報告研究了全球心肺旁路設備市場，並提供了市場概述，包括依產品、應用、最終用戶、地區的趨勢，以及進入市場的公司概況。

目錄

第1章 心肺旁路設備市場報告簡介

第2章 心肺旁路設備市場執行摘要

第3章 競爭態勢

第4章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第5章 體外循環設備市場主要因素分析

  • 心肺旁路設備市場驅動因素
  • 限制體外循環設備市場的因素與挑戰
  • 體外循環設備的市場機會

第6章 心肺旁通設備市場的波特五力分析

第7章 體外循環設備市場評估

  • 依產品
    • 心肺機
    • 供氧裝置
    • 自體輸血系統
    • 其他
  • 依用途
    • 心血管
    • 呼吸系統
    • 血液透析
  • 依最終用戶
    • 醫院
    • 專科診所
    • 透析中心
    • 門診手術中心
  • 地區
    • 北美
    • 歐洲
    • 亞太地區
    • 其他領域

第8章 體外循環設備市場公司及產品概況

  • Medtronic plc.
  • LivaNova PLC
  • MAQUET Holding B.V. & Co. KG.
  • ABIOMED
  • Braile Biomedica Ltd.
  • Tianjin Medical
  • Terumo Corp.
  • Senko Medical Instrument Manufacturing Co.,Ltd.
  • Technowood Corp
  • Sorin
  • MicroPort Scientific Corporation
  • Xenios AG
  • Nipro Corporation
  • OriGen Biomedical
  • Thoratec Corporation
  • Inspira Technologies OXY B.H.N. Ltd.
  • Xenios AG
  • Boston Scientific Corporation
  • Cardinal Health
  • B. Braun

第9章 KOL觀點

第10章 專案方法

第11章 關於 DelveInsight

第12章 免責聲明與聯絡我們

Product Code: DIMDCL0054

Cardiopulmonary Bypass Equipment Market by Product (Heart-Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising burden of cardiovascular diseases and respiratory diseases, increasing number of surgical procedures, increasing awareness and screening programs, and increase in product launches and approvals by key market players across the globe.

The cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2023, growing at a CAGR of 4.14% during the forecast period from 2024 to 2030, to reach USD 516.82 million by 2030. The demand for cardiopulmonary bypass equipment is motivated by a rise in the prevalence of cardiovascular and respiratory diseases globally which has led to an increased need for surgical interventions. Conditions such as coronary artery disease, heart failure, and congenital heart defects often require complex surgeries, which are facilitated by cardiopulmonary bypass equipment. Secondly, the increasing number of surgical procedures, driven by an aging population and advancements in medical technology, has heightened the demand for cardiopulmonary bypass equipment. More surgeries translate to a greater need for reliable and efficient cardiopulmonary bypass equipment. Thirdly, growing awareness and screening programs are contributing to the early detection and diagnosis of cardiovascular and respiratory conditions. Early detection often leads to timely surgical interventions, further driving the demand for cardiopulmonary bypass equipment. Furthermore, the increase in product launches and approvals by key market players across the globe has expanded the availability and accessibility of advanced cardiopulmonary bypass equipment. Innovations in technology and design improvements are resulting in more efficient, safer, and user-friendly equipment, which enhances the adoption rates among healthcare providers during the forecast period from 2024 to 2030.

Cardiopulmonary Bypass Equipment Market Dynamics:

According to recent data provided by the British Heart Foundation (2024), globally, approximately 620 million people, or about 1 in 13 individuals, live with heart and circulatory diseases. Additionally, as per the same source, the prevalence of heart and circulatory diseases was 100 million in Europe and 340 million in Asia and Australia in 2021. Furthermore, as per the recent data provided by the British Heart Foundation (2024), coronary (ischemic) heart disease, the most commonly diagnosed worldwide, affects an estimated 200 million people globally. Approximately 110 million men and 80 million women are affected. Additionally, around 56 million women and 45 million men are stroke survivors. It is estimated that at least 13 million people worldwide live with congenital heart disease, with potentially millions more undiagnosed.

According to the World Heart Federation (2024), approximately 60 million population are affected by atrial fibrillation which is one of the most common types of irregular heartbeat, or arrhythmia. It can increase the risk of blood clots, heart failure, and stroke. Additionally, as per the same source people with atrial fibrillation are 5X times more likely to suffer a stroke.

Furthermore, according to the recent data and stats provided by the Australian Institute of Health and Welfare (2024), in 2021, more than 500,000 population were affected by atrial fibrillation.

Heart and circulatory diseases, including coronary (ischemic) heart disease, atrial fibrillation, and stroke, collectively drive the demand for cardiopulmonary bypass equipment due to their prevalence and the complexity of treatments often requiring surgical intervention. These surgeries depend heavily on cardiopulmonary bypass equipment to maintain circulatory and respiratory functions. Coronary heart disease, resulting from plaque buildup and reduced blood flow, frequently necessitates coronary artery bypass grafting (CABG), significantly boosting cardiopulmonary bypass equipment demand. Atrial fibrillation, the most common arrhythmia, increases stroke and heart failure risks, leading to surgeries like the maze procedure or catheter ablation, which also rely on cardiopulmonary bypass support. Similarly, strokes caused by blood flow blockages often require surgical interventions that depend on cardiopulmonary bypass equipment to restore circulation, further driving market growth globally.

Additionally, companies are amplifying their production of cardiopulmonary bypass equipment and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in July 2024, Inspira(TM) Technologies OXY B.H.N. Ltd. received the Israeli Ministry of Health's medical devices and accessories ("AMAR") approval for the INSPIRA(TM) ART100, an extra-corporeal membrane oxygenation and cardiopulmonary bypass system.

Thus, the factors mentioned above are likely to boost the market for cardiopulmonary bypass equipment during the forecasted period.

However, cardiopulmonary bypass equipment can lead to various complications, including bleeding, infection, neurological deficits, renal dysfunction, and respiratory issues, and stringent regulatory concerns for product approval may hinder the future market of cardiopulmonary bypass equipment.

Cardiopulmonary Bypass Equipment Market Segment Analysis:

Cardiopulmonary Bypass Equipment Market by Product (Heart-Lung Machines, Oxygenators, Autotransfusion Systems, and Others), Application (Cardiovascular, Respiratory, Hemodialysis, and Others), End-User (Hospitals, Specialty Clinics, Dialysis Centers, and Ambulatory Surgery Centers), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product segment of the cardiopulmonary bypass equipment market, heart-lung machines are projected to hold a considerable market share in 2023. Heart-lung machines, a critical component of cardiopulmonary bypass (CPB) systems, play a pivotal role in boosting the overall market for CPB equipment by enhancing the scope and efficacy of cardiac and thoracic surgeries. These machines temporarily assume the functions of the heart and lungs, allowing for complex surgical procedures on a still and bloodless heart, which is essential for precision in surgeries such as coronary artery bypass grafting (CABG), heart valve replacements, and heart transplants. The growing prevalence of cardiovascular diseases and respiratory diseases has driven an increasing number of surgical interventions that rely on heart-lung machines. For instance, according to the latest data provided by the Australian Institute of Health and Welfare, in 2022, around 8.5 million (34%) people in Australia were estimated to have chronic respiratory conditions. Thus, as the cases of respiratory disorders and cardiovascular diseases increase so does the demand for such high-risk and intricate procedures, which also increases the need for advanced heart-lung machines, fueling the market growth. Innovations in heart-lung machine technology such as improved oxygenators, more efficient pumps, and enhanced biocompatibility have led to better patient outcomes, fewer complications, and increased acceptance among healthcare providers.

Additionally, the regulatory approvals and advancements in technology have further bolstered market growth by providing more reliable and sophisticated equipment options, thus encouraging widespread adoption. For instance, in April 2022, LivaNova received FDA 510(k) clearance for its B-Capta system integrated into the S5 heart-lung machine.

Therefore, owing to the above-mentioned factors, the heart-lung machines category is expected to generate considerable revenue thereby pushing the overall growth of the cardiopulmonary bypass equipment market during the forecast period.

North America is expected to dominate the overall cardiopulmonary bypass equipment market:

North America is expected to account for the highest proportion of the cardiopulmonary bypass equipment market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cardiac disease and respiratory disease across the region, increased government initiatives coupled with increased awareness programs for cardiac and respiratory disease, and the presence of key market players engaged in mergers, acquisitions, product launches, and other market activities across the region are expected to escalate the market of cardiopulmonary bypass equipment during the forecast period.

According to recent data from the Centers for Disease Control and Prevention (2024), approximately 4.9% of adults were diagnosed with coronary heart disease in 2022. Furthermore, by 2023, an estimated 12.1 million individuals in the United States were projected to have atrial fibrillation. Additionally, each year, over 795,000 people in the U.S. experience a stroke, with around 610,000 of these being first-time strokes. Notably, nearly 185,000 of these strokes, or about one in four, occur in individuals who have previously had a stroke.

Moreover, as per the recent data provided by the Centre for Disease Control and Prevention (2024), approximately 900,000 people in the United States are affected by venous thromboembolism (VTE, a blood clot), each year. Furthermore, as per the same source, in 2022, approximately 4.6% of U.S. adults have been diagnosed with COPD, emphysema, or chronic bronchitis.

Coronary heart disease frequently leads to severe cases requiring coronary artery bypass grafting, which relies heavily on cardiopulmonary bypass equipment to maintain heart and lung function during surgery. Atrial fibrillation, with its increased risk of stroke and heart failure, often necessitates surgical procedures that depend on cardiopulmonary bypass equipment systems for stable circulation and oxygenation. Stroke, particularly in its severe forms, may require surgical interventions to restore proper blood flow, again driving the need for cardiopulmonary bypass equipment. Furthermore, venous thromboembolism, involving conditions like deep vein thrombosis and pulmonary embolism, sometimes necessitates surgical removal of clots, a procedure that also benefits from cardiopulmonary bypass equipment support. COPD patients undergoing lung volume reduction surgery or lung transplantation require cardiopulmonary bypass equipment systems to manage their circulatory and respiratory functions during complex procedures. The high incidence of these conditions is escalating the market of cardiopulmonary bypass equipment across the region.

Additionally, the awareness programs in the United States aimed at addressing cardiac diseases focus on education, prevention, and early detection also boost the market of Cardiopulmonary Bypass Equipment across the region as public awareness campaigns educate individuals about the importance of regular screenings and preventive measures. For example, February is designated as American Heart Month, during which various organizations, including the American Heart Association (AHA) and the Centers for Disease Control and Prevention (CDC), promote awareness through campaigns, events, and educational materials. These efforts emphasize the importance of heart health, risk factors, and preventive measures.

The increasing number of product development activities in the region is further going to accelerate the growth of the cardiopulmonary bypass equipment market. For example, in March 2023 the US Food and Drug Administration (FDA) granted 510(k) clearance to LivaNova's Essenz heart-lung machine (HLM) for use in cardiopulmonary bypass (CPB) procedures.

Therefore, the above-mentioned factors are expected to bolster the growth of the cardiopulmonary bypass equipment market in North America during the forecast period.

Cardiopulmonary Bypass Equipment Market Key Players:

Some of the key market players operating in the cardiopulmonary bypass equipment market include Medtronic plc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., ABIOMED, Braile Biomedica Ltda, Tianjin Medical, Terumo Corp, Senko Medical Instrument Manufacturing Co., Ltd., Technowood Corp, Sorin, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, OriGen Biomedical, Thoratec Corporation, Inspira Technologies OXY B.H.N. Ltd., Xenios AG, Boston Scientific, Cardinal Health, B. Braun, and others.

Recent Developmental Activities in the Cardiopulmonary Bypass Equipment Market:

  • In May 2024, Terumo Corporation, a global leader in cardiovascular surgery technologies, announced that the U.S. Food and Drug Administration (FDA) had granted 510(k) clearance for the CDI OneView Monitoring System. This next-generation CDI Systems platform provided enhanced visibility of key patient parameters during cardiopulmonary bypass surgery
  • In August 2022, the FDA awarded breakthrough privileges to Abiomed's Impella ECP expandable percutaneous heart pump.

Key Takeaways From the Cardiopulmonary Bypass Equipment Market Report Study:

  • Market size analysis for current cardiopulmonary bypass equipment size (2023), and market forecast for 6 years (2024 to 2030)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
  • Key companies dominating the cardiopulmonary bypass equipment market.
  • Various opportunities available for the other competitors in the cardiopulmonary bypass equipment market space.
  • What are the top-performing segments in 2023? How these segments will perform in 2030?
  • Which are the top-performing regions and countries in the current cardiopulmonary bypass equipment market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for cardiopulmonary bypass equipment market growth in the coming future?

Target Audience who can be Benefited From This Cardiopulmonary Bypass Equipment Market Report Study:

  • Cardiopulmonary bypass equipment product providers
  • Research organizations and consulting companies
  • Cardiopulmonary bypass equipment -related organizations, associations, forums, and other alliances
  • Government and corporate offices
  • Start-up companies, venture capitalists, and private equity firms
  • Distributors and traders dealing in cardiopulmonary bypass equipment
  • Various end-users want to know more about the cardiopulmonary bypass equipment market and the latest technological developments in the cardiopulmonary bypass equipment market.

Frequently Asked Questions for the Cardiopulmonary Bypass Equipment Market:

1. What are cardiopulmonary bypass equipment?

Cardiopulmonary bypass (CPB) equipment provides a bloodless field for cardiac surgery and does the work of both the heart (i.e., pumps blood) and the lungs (i.e., oxygenates the blood). CPB circuit includes pumps, cannulae, tubing, reservoir, oxygenator, heat exchanger, and arterial line filter. Cardiopulmonary bypass machines are operated by perfusionists to bypass the heart and lungs during open-heart surgery.

2. What is the market for cardiopulmonary bypass equipment?

The cardiopulmonary bypass equipment market was valued at USD 405.18 million in 2023, growing at a CAGR of 4.14% during the forecast period from 2024 to 2030, to reach USD 516.82 million by 2030.

3. What are the drivers for the cardiopulmonary bypass equipment market?

The demand for cardiopulmonary bypass equipment is motivated by a rise in the prevalence of cardiovascular and respiratory diseases globally which has led to an increased need for surgical interventions. Conditions such as coronary artery disease, heart failure, and congenital heart defects often require complex surgeries, which are facilitated by cardiopulmonary bypass equipment. Secondly, the increasing number of surgical procedures, driven by an aging population and advancements in medical technology, has heightened the demand for cardiopulmonary bypass equipment. More surgeries translate to a greater need for reliable and efficient cardiopulmonary bypass equipment. Thirdly, growing awareness and screening programs are contributing to the early detection and diagnosis of cardiovascular and respiratory conditions. Early detection often leads to timely surgical interventions, further driving the demand for cardiopulmonary bypass equipment. Furthermore, the increase in product launches and approvals by key market players across the globe has expanded the availability and accessibility of advanced cardiopulmonary bypass equipment. Innovations in technology and design improvements are resulting in more efficient, safer, and user-friendly equipment, which enhances the adoption rates among healthcare providers during the forecast period from 2024 to 2030.

4. Who are the key players operating in the cardiopulmonary bypass equipment market?

Some of the key market players operating in the Cardiopulmonary Bypass Equipment market include Medtronic plc., LivaNova PLC, MAQUET Holding B.V. & Co. KG., ABIOMED, Braile Biomedica Ltda, Tianjin Medical, Terumo Corp, Senko Medical Instrument Manufacturing Co., Ltd., Technowood Corp, Sorin, MicroPort Scientific Corporation, Xenios AG, Nipro Corporation, OriGen Biomedical, Thoratec Corporation, Inspira Technologies OXY B.H.N. Ltd., Xenios AG, Boston Scientific, Cardinal Health, B. Braun, and others.

5. Which region has the highest share in the cardiopulmonary bypass equipment market?

North America is expected to account for the highest proportion of the cardiopulmonary bypass equipment market in 2023, out of all regions. This can be ascribed to the increasing prevalence of cardiac disease and respiratory disease across the region, increased government initiatives coupled with increased awareness programs for cardiac and respiratory disease, and the presence of key market players engaged in merges, acquisition, product launches, and other market activities across the region are expected to escalate the market of cardiopulmonary bypass equipment during the forecast period.

Table of Contents

1. Cardiopulmonary Bypass Equipment Market Report Introduction

  • 1.1. Scope of the Study
  • 1.2. Market Segmentation
  • 1.3. Market Assumption

2. Cardiopulmonary Bypass Equipment Market Executive Summary

  • 2.1. Market at Glance

3. Competitive Landscape

4. Regulatory Analysis

  • 4.1. The United States
  • 4.2. Europe
  • 4.3. Japan
  • 4.4. China

5. Cardiopulmonary Bypass Equipment Market Key Factors Analysis

  • 5.1. Cardiopulmonary Bypass Equipment Market Drivers
    • 5.1.1. The rising burden of cardiac diseases and respiratory disease
    • 5.1.2. Increasing number of surgical procedures
    • 5.1.3. Increasing awareness and screening programs
    • 5.1.4. Increase in product launches and approvals by key market players across the globe
  • 5.2. Cardiopulmonary Bypass Equipment Market Restraints and Challenges
    • 5.2.1. Cardiopulmonary bypass equipment carries risks such as bleeding, infection, neurological deficits, renal dysfunction, and respiratory issues
    • 5.2.2. Stringent regulatory concerns for product approval
  • 5.3. Cardiopulmonary Bypass Equipment Market Opportunities
    • 5.3.1. Integration of cardiopulmonary bypass equipment with emerging technologies like artificial intelligence (AI) and machine learning

6. Cardiopulmonary Bypass Equipment Market Porter's Five Forces Analysis

  • 6.1. Bargaining Power of Suppliers
  • 6.2. Bargaining Power of Consumers
  • 6.3. Threat of New Entrants
  • 6.4. Threat of Substitutes
  • 6.5. Competitive Rivalry

7. Cardiopulmonary Bypass Equipment Market Assessment

  • 7.1. By Product
    • 7.1.1. Heart-Lung Machines
    • 7.1.2. Oxygenators
    • 7.1.3. Autotransfusion Systems
    • 7.1.4. Others
  • 7.2. By Application
    • 7.2.1. Cardiovascular
    • 7.2.2. Respiratory
    • 7.2.3. Hemodialysis
    • 7.2.4. Others
  • 7.3. By End-User
    • 7.3.1. Hospitals
    • 7.3.2. Specialty Clinics
    • 7.3.3. Dialysis Centers
    • 7.3.4. Ambulatory Surgical Centers
  • 7.4. By Geography
    • 7.4.1. North America
      • 7.4.1.1. United States Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.1.2. Canada Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.1.3. Mexico Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
    • 7.4.2. Europe
      • 7.4.2.1. France Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.2.2. Germany Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.2.3. United Kingdom Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.2.4. Italy Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.2.5. Spain Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.2.6. Rest of Europe Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
    • 7.4.3. Asia-Pacific
      • 7.4.3.1. China Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.3.2. Japan Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.3.3. India Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.3.4. Australia Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.3.5. South Korea Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.3.6. Rest of Asia-Pacific Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
    • 7.4.4. Rest of the World (RoW)
      • 7.4.4.1. Middle East Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.4.2. Africa Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)
      • 7.4.4.3. South America Cardiopulmonary Bypass Equipment Market Size in USD Million (2021-2030)

8. Cardiopulmonary Bypass Equipment Market Company and Product Profiles

  • 8.1. Medtronic plc.
    • 8.1.1. Company Overview
    • 8.1.2. Company Snapshot
    • 8.1.3. Financial Overview
    • 8.1.4. Product Listing
    • 8.1.5. Entropy
  • 8.2. LivaNova PLC
    • 8.2.1. Company Overview
    • 8.2.2. Company Snapshot
    • 8.2.3. Financial Overview
    • 8.2.4. Product Listing
    • 8.2.5. Entropy
  • 8.3. MAQUET Holding B.V. & Co. KG.
    • 8.3.1. Company Overview
    • 8.3.2. Company Snapshot
    • 8.3.3. Financial Overview
    • 8.3.4. Product Listing
    • 8.3.5. Entropy
  • 8.4. ABIOMED
    • 8.4.1. Company Overview
    • 8.4.2. Company Snapshot
    • 8.4.3. Financial Overview
    • 8.4.4. Product Listing
    • 8.4.5. Entropy
  • 8.5. Braile Biomedica Ltd.
    • 8.5.1. Company Overview
    • 8.5.2. Company Snapshot
    • 8.5.3. Financial Overview
    • 8.5.4. Product Listing
    • 8.5.5. Entropy
  • 8.6. Tianjin Medical
    • 8.6.1. Company Overview
    • 8.6.2. Company Snapshot
    • 8.6.3. Financial Overview
    • 8.6.4. Product Listing
    • 8.6.5. Entropy
  • 8.7. Terumo Corp.
    • 8.7.1. Company Overview
    • 8.7.2. Company Snapshot
    • 8.7.3. Financial Overview
    • 8.7.4. Product Listing
    • 8.7.5. Entropy
  • 8.8. Senko Medical Instrument Manufacturing Co.,Ltd.
    • 8.8.1. Company Overview
    • 8.8.2. Company Snapshot
    • 8.8.3. Financial Overview
    • 8.8.4. Product Listing
    • 8.8.5. Entropy
  • 8.9. Technowood Corp
    • 8.9.1. Company Overview
    • 8.9.2. Company Snapshot
    • 8.9.3. Financial Overview
    • 8.9.4. Product Listing
    • 8.9.5. Entropy
  • 8.10. Sorin
    • 8.10.1. Company Overview
    • 8.10.2. Company Snapshot
    • 8.10.3. Financial Overview
    • 8.10.4. Product Listing
    • 8.10.5. Entropy
  • 8.11. MicroPort Scientific Corporation
    • 8.11.1. Company Overview
    • 8.11.2. Company Snapshot
    • 8.11.3. Financial Overview
    • 8.11.4. Product Listing
    • 8.11.5. Entropy
  • 8.12. Xenios AG
    • 8.12.1. Company Overview
    • 8.12.2. Company Snapshot
    • 8.12.3. Financial Overview
    • 8.12.4. Product Listing
    • 8.12.5. Entropy
  • 8.13. Nipro Corporation
    • 8.13.1. Company Overview
    • 8.13.2. Company Snapshot
    • 8.13.3. Financial Overview
    • 8.13.4. Product Listing
    • 8.13.5. Entropy
  • 8.14. OriGen Biomedical
    • 8.14.1. Company Overview
    • 8.14.2. Company Snapshot
    • 8.14.3. Financial Overview
    • 8.14.4. Product Listing
    • 8.14.5. Entropy
  • 8.15. Thoratec Corporation
    • 8.15.1. Company Overview
    • 8.15.2. Company Snapshot
    • 8.15.3. Financial Overview
    • 8.15.4. Product Listing
    • 8.15.5. Entropy
  • 8.16. Inspira Technologies OXY B.H.N. Ltd.
    • 8.16.1. Company Overview
    • 8.16.2. Company Snapshot
    • 8.16.3. Financial Overview
    • 8.16.4. Product Listing
    • 8.16.5. Entropy
  • 8.17. Xenios AG
    • 8.17.1. Company Overview
    • 8.17.2. Company Snapshot
    • 8.17.3. Financial Overview
    • 8.17.4. Product Listing
    • 8.17.5. Entropy
  • 8.18. Boston Scientific Corporation
    • 8.18.1. Company Overview
    • 8.18.2. Company Snapshot
    • 8.18.3. Financial Overview
    • 8.18.4. Product Listing
    • 8.18.5. Entropy
  • 8.19. Cardinal Health
    • 8.19.1. Company Overview
    • 8.19.2. Company Snapshot
    • 8.19.3. Financial Overview
    • 8.19.4. Product Listing
    • 8.19.5. Entropy
  • 8.20. B. Braun
    • 8.20.1. Company Overview
    • 8.20.2. Company Snapshot
    • 8.20.3. Financial Overview
    • 8.20.4. Product Listing
    • 8.20.5. Entropy

9. KOL Views

10. Project Approach

11. About DelveInsight

12. Disclaimer & Contact Us

List of Tables

  • Table 1: Competitive Analysis
  • Table 2: Cardiopulmonary Bypass Equipment Market in Global (2021-2030)
  • Table 3: Cardiopulmonary Bypass Equipment Market in Global by Product (2021-2030)
  • Table 4: Cardiopulmonary Bypass Equipment Market in Global by Application (2021-2030)
  • Table 5: Cardiopulmonary Bypass Equipment Market in Global by End-User (2021-2030)
  • Table 6: Cardiopulmonary Bypass Equipment Market in Global by Geography (2021-2030)
  • Table 7: Cardiopulmonary Bypass Equipment Market in North America (2021-2030)
  • Table 8: Cardiopulmonary Bypass Equipment Market in the United States (2021-2030)
  • Table 9: Cardiopulmonary Bypass Equipment Market in Canada (2021-2030)
  • Table 10: Cardiopulmonary Bypass Equipment Market in Mexico (2021-2030)
  • Table 11: Cardiopulmonary Bypass Equipment Market in Europe (2021-2030)
  • Table 12: Cardiopulmonary Bypass Equipment Market in France (2021-2030)
  • Table 13: Cardiopulmonary Bypass Equipment Market in Germany (2021-2030)
  • Table 14: Cardiopulmonary Bypass Equipment Market in United Kingdom (2021-2030)
  • Table 15: Cardiopulmonary Bypass Equipment Market in Italy (2021-2030)
  • Table 16: Cardiopulmonary Bypass Equipment Market in Spain (2021-2030)
  • Table 17: Cardiopulmonary Bypass Equipment Market in the Rest of Europe (2021-2030)
  • Table 18: Cardiopulmonary Bypass Equipment Market in Asia-Pacific (2021-2030)
  • Table 19: Cardiopulmonary Bypass Equipment Market in China (2021-2030)
  • Table 20: Cardiopulmonary Bypass Equipment Market in Japan (2021-2030)
  • Table 21: Cardiopulmonary Bypass Equipment Market in India (2021-2030)
  • Table 22: Cardiopulmonary Bypass Equipment Market in Australia (2021-2030)
  • Table 23: Cardiopulmonary Bypass Equipment Market in South Korea (2021-2030)
  • Table 24: Cardiopulmonary Bypass Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Table 25: Cardiopulmonary Bypass Equipment Market in the Rest of the World (2021-2030)
  • Table 26: Cardiopulmonary Bypass Equipment Market in the Middle East (2021-2030)
  • Table 27: Cardiopulmonary Bypass Equipment Market in Africa (2021-2030)
  • Table 28: Cardiopulmonary Bypass Equipment Market in South America (2021-2030)

List of Figures

  • Figure 1: Competitive Analysis
  • Figure 2: Cardiopulmonary Bypass Equipment Market in Global (2021-2030)
  • Figure 3: Cardiopulmonary Bypass Equipment Market in Global by Product (2021-2030)
  • Figure 4: Cardiopulmonary Bypass Equipment Market in Global by Application (2021-2030)
  • Figure 5: Cardiopulmonary Bypass Equipment Market in Global by End-User (2021-2030)
  • Figure 6: Cardiopulmonary Bypass Equipment Market in Global by Geography (2021-2030)
  • Figure 7: Cardiopulmonary Bypass Equipment Market in North America (2021-2030)
  • Figure 8: Cardiopulmonary Bypass Equipment Market in the United States (2021-2030)
  • Figure 9: Cardiopulmonary Bypass Equipment Market in Canada (2021-2030)
  • Figure 10: Cardiopulmonary Bypass Equipment Market in Mexico (2021-2030)
  • Figure 11: Cardiopulmonary Bypass Equipment Market in Europe (2021-2030)
  • Figure 12: Cardiopulmonary Bypass Equipment Market in France (2021-2030)
  • Figure 13: Cardiopulmonary Bypass Equipment Market in Germany (2021-2030)
  • Figure 14: Cardiopulmonary Bypass Equipment Market in United Kingdom (2021-2030)
  • Figure 15: Cardiopulmonary Bypass Equipment Market in Italy (2021-2030)
  • Figure 16: Cardiopulmonary Bypass Equipment Market in Spain (2021-2030)
  • Figure 17: Cardiopulmonary Bypass Equipment Market in the Rest of Europe (2021-2030)
  • Figure 18: Cardiopulmonary Bypass Equipment Market in Asia-Pacific (2021-2030)
  • Figure 19: Cardiopulmonary Bypass Equipment Market in China (2021-2030)
  • Figure 20: Cardiopulmonary Bypass Equipment Market in Japan (2021-2030)
  • Figure 21: Cardiopulmonary Bypass Equipment Market in India (2021-2030)
  • Figure 22: Cardiopulmonary Bypass Equipment Market in Australia (2021-2030)
  • Figure 23: Cardiopulmonary Bypass Equipment Market in South Korea (2021-2030)
  • Figure 24: Cardiopulmonary Bypass Equipment Market in Rest of Asia-Pacific (2021-2030)
  • Figure 25: Cardiopulmonary Bypass Equipment Market in the Rest of the World (2021-2030)
  • Figure 26: Cardiopulmonary Bypass Equipment Market in the Middle East (2021-2030)
  • Figure 27: Cardiopulmonary Bypass Equipment Market in Africa (2021-2030)
  • Figure 28: Cardiopulmonary Bypass Equipment Market in South America (2021-2030)
  • Figure 29: Market Drivers
  • Figure 30: Market Barriers
  • Figure 31: Market Opportunities
  • Figure 32: PORTER'S Five Force Analysis